Tag Archives: MI

Blanket prescribing of beta-blockers to all patients with CAD or at risk of CAD does not reduce cardiovascular risk

Beta-blocker therapy is not associated with a lower risk of death, nonfatal myocardial infarction (MI), and nonfatal stroke in patients with coronary artery disease (CAD) risk factors, known CAD without MI, or prior MI, according to a recent observational study. “…Trends are changing, and the evidence is compelling to use… 

Read more »
Posted in Cardiovascular, Pharmacology, Primary Care | Also tagged , , , , , , , , , | Volume: | Leave a comment

Is chronic kidney disease a coronary heart disease risk equivalent?

Patients with chronic kidney disease (CKD) have an increased risk of myocardial infarction (MI) and a higher MI mortality rate as compared with patients diagnosed with diabetes or who have had a prior MI event, according to a recently published study. “Chronic kidney disease in India is a public health… 

Read more »
Posted in Cardiovascular, Non-Communicable Disease, Primary Care | Also tagged , , , , , , , , , , , , , , | Volume: | Leave a comment

Insulin has neutral effect on cardiovascular disease, cancer when used early in type 2 diabetes

mdCurrent Conference Report: 72nd Annual Scientific Sessions of the American Diabetes Association Basal insulin in patients with prediabetes or newly diagnosed type 2 diabetes has no effect on cardiovascular disease events over a median follow-up of 6.2 years, according to a recent study. An estimated 62 million people nationwide are… 

Read more »
Posted in Cardiovascular, Diabetes, Non-Communicable Disease, Primary Care | Also tagged , , , , , , , , , , , , , , , , , , , , , , | Volume: | Leave a comment

Use of beta-blockers and aspirin in cancer patients with acute myocardial infarction prolongs survival

In patients with cancer who had an acute myocardial infarction (AMI) the use of beta-blockers and aspirin were each associated with improved survival. The population was primarily comprised of patients with non-ST-segment elevation myocardial infarction (NSTEMI). This was the main finding of a recent observational study published in Clinical Cardiology…. 

Read more »
Posted in Cardiovascular Disease, Oncology, Pharmacology | Also tagged , , , , , , | Volume: | Leave a comment

Galectin-3 identifies subset of heart failure patients who can benefit from a statin

Blood levels of the carbohydrate-binding protein galectin-3 identified patients with ischemic heart failure who derived significant clinical benefit from rosuvastatin in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA) trial. A substudy of CORONA demonstrated that patients with blood levels of galectin-3 <19.0 ng/mL at the start of the… 

Read more »
Posted in Cardiovascular Disease, Pharmacology, Primary Care | Also tagged , , , , , , , , , | Volume: | Leave a comment

Outcomes equal between medical therapy and cardiac stents in stable coronary artery disease

Optimal medical therapy works equally as well as implanting a coronary artery stent in patients with stable coronary artery disease to prevent death, nonfatal myocardial infarction (MI), unplanned revascularization, or angina, a new meta-analysis has found. With coronary artery disease (CAD) on the rise in India, industry estimates place the… 

Read more »
Posted in Cardiology, Cardiovascular, Cardiovascular Disease, Primary Care | Also tagged , , , , , , , , , , | Volume: | 1 Response

Meta-analysis examines whether aspirin is worth the risk for primary prevention

Despite clinically relevant reductions in nonfatal myocardial infarction (MI), the use of aspirin in patients without a history of cardiovascular disease (CVD) does not lead to reductions in either cardiovascular- or cancer-related death, according to a recently published meta-analysis. The incidence of CVD in India is on the rise and… 

Read more »
Posted in Cardiology, Cardiovascular Disease, Pharmacology | Also tagged , , , , , , , , | Volume: | Leave a comment